SlateStone Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Sell |
5,790
-120
| -2% | -$15.2K | 0.07% | 176 |
|
|
2025
Q1 | $756K | Sell |
5,910
-390
| -6% | -$49.9K | 0.08% | 169 |
|
|
2024
Q4 | $833K | Sell |
6,300
-15,241
| -71% | -$2.02M | 0.08% | 169 |
|
|
2024
Q3 | $3.14M | Sell |
21,541
-170
| -0.8% | -$24.7K | 0.28% | 82 |
|
|
2024
Q2 | $2.98M | Sell |
21,711
-500
| -2% | -$68.6K | 0.32% | 74 |
|
|
2024
Q1 | $3.05M | Sell |
22,211
-4,145
| -16% | -$569K | 0.31% | 77 |
|
|
2023
Q4 | $3.58M | Buy |
26,356
+906
| +4% | +$123K | 0.46% | 59 |
|
|
2023
Q3 | $3.11M | Sell |
25,450
-1,000
| -4% | -$122K | 0.45% | 59 |
|
|
2023
Q2 | $3.36M | Buy |
26,450
+885
| +3% | +$112K | 0.63% | 36 |
|
|
2023
Q1 | $3.3M | Hold |
25,565
| – | – | 0.68% | 35 |
|
|
2022
Q4 | $3.36M | Hold |
25,565
| – | – | 0.81% | 30 |
|
|
2022
Q3 | $2.99M | Sell |
25,565
-50
| -0.2% | -$5.85K | 0.8% | 31 |
|
|
2022
Q2 | $3.01M | Hold |
25,615
| – | – | 0.77% | 30 |
|
|
2022
Q1 | $3.34M | Sell |
25,615
-710
| -3% | -$92.5K | 0.74% | 32 |
|
|
2021
Q4 | $4.02M | Buy |
26,325
+1,050
| +4% | +$160K | 0.86% | 29 |
|
|
2021
Q3 | $4.09M | Hold |
25,275
| – | – | 0.94% | 27 |
|
|
2021
Q2 | $4.14M | Hold |
25,275
| – | – | 0.95% | 27 |
|
|
2021
Q1 | $3.81M | Sell |
25,275
-150
| -0.6% | -$22.6K | 0.94% | 26 |
|
|
2020
Q4 | $3.85M | Sell |
25,425
-155
| -0.6% | -$23.5K | 0.96% | 27 |
|
|
2020
Q3 | $3.46M | Hold |
25,580
| – | – | 0.75% | 45 |
|
|
2020
Q2 | $3.5M | Buy |
25,580
+530
| +2% | +$72.5K | 0.78% | 32 |
|
|
2020
Q1 | $2.7M | Sell |
25,050
-300
| -1% | -$32.3K | 0.77% | 37 |
|
|
2019
Q4 | $3.06M | Sell |
25,350
-525
| -2% | -$63.3K | 0.7% | 42 |
|
|
2019
Q3 | $2.58M | Sell |
25,875
-2,050
| -7% | -$204K | 0.75% | 34 |
|
|
2019
Q2 | $3.05M | Sell |
27,925
-6,000
| -18% | -$655K | 0.86% | 32 |
|
|
2019
Q1 | $3.79M | Hold |
33,925
| – | – | 1.16% | 26 |
|
|
2018
Q4 | $3.27M | Buy |
+33,925
| New | +$3.27M | 1.5% | 17 |
|